Sarah A. Taylor

Sarah A. Taylor

Auto-generated profile, based on publicly available information

Sarah A. Taylor

Department of Pediatrics, Pediatric Liver Center, Digestive Health Institute and Section of Pediatric Gastroenterology, Hepatology & Nutrition Children's Hospital Colorado, University of Colorado Anschutz Medical Campus Aurora Colorado USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2016 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
STSarah A. Taylor
Sarah A. Taylor
PWPeter F. Whitington
Peter F. Whitington

24 June 2022 in Clinics in Liver Disease
Verified
Journal Article
Closed access
SASwati Antala
Swati Antala
STSarah A. Taylor
Sarah A. Taylor

5 October 2018 in Hepatology
Verified
Journal Article
Closed access
PDF file
STSarah A. Taylor
Sarah A. Taylor
RGRichard M. Green
Richard M. Green

7 February 2023 in Liver Transplantation
Verified
Journal Article
Open access
GMGeorge V. Mazariegos
George V. Mazariegos
EPEmily R. Perito
Emily R. Perito
JSJames E. Squires
James E. Squires
KSKyle A. Soltys
Kyle A. Soltys
AGAdam D. Griesemer
Adam D. Griesemer
EPEric Pahl
Eric Pahl
To assess the impact of technical variant grafts (TVGs) [including living donor (LD) and deceased donor split/partial grafts] on waitlist (WL) and transplant outcomes for pediatric liver transplant (LT) candidates, we performed a retrospective analysis of Organ Procurement and Transplantation Network (OPTN) data on first-time LT or liver-kidney pediatric candidates listed at centers that performed >10 LTs during the study period, 2004–2020. Center variance was plotted for LT volume, TVG usage, and survival. A composite center metric of TVG usage and WL mortality was developed to demonstrate the existing variation and potential for improvement. Sixty-four centers performed 7842 LTs; 657 children died on the WL. Proportions of WL mortality by center ranged from 0% to 31% and those of TVG usage from 0% to 76%. Higher TVG usage, from deceased donor or LD, independently or in combination, significantly correlated with lower WL mortality. In multivariable analyses, death from listing was significantly lower with increased center TVG usage (HR = 0.611, CI: 0.40–0.92) and LT volume (HR = 0.995, CI: 0.99–1.0). Recipients of LD transplants (HR = 0.637, CI: 0.51–0.79) had significantly increased survival from transplant compared with other graft types, and recipients of deceased donor TVGs (HR = 1.066, CI: 0.93–1.22) had statistically similar outcomes compared with whole graft recipients. Increased TVG utilization may decrease WL mortality in the US. Hence, policy and training to increase TVG usage, availability, and expertise are critical.

1 May 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
STSarah A. Taylor
Sarah A. Taylor
SKSusan Kelly
Susan Kelly
EAEstella M. Alonso
Estella M. Alonso
PWPeter F. Whitington
Peter F. Whitington

1 April 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
STSarah A. Taylor
Sarah A. Taylor
VVVeena Venkat
Veena Venkat
RARonen Arnon
Ronen Arnon
VGVani V. Gopalareddy
Vani V. Gopalareddy
PRPhilip Rosenthal
Philip Rosenthal
JDJames F. Daniel
James F. Daniel